Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.All patients who fit into the description of community acquired pneumonia described below were included in the study. -One or more of the symptoms of pneumonia like fever, cough, dyspnoea, haemoptysis or chest pain with -Clinical examination showing features of consolidation and. -Radio-logical features of consolidation. 2 Age greater than 18 years. 3 patient willing to give informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients who had history, clinical and Echo-cardio graphic evidence of heart disease. 2.Patients with clinical, biochemical and radio-logical evidence of chronic kidney disease, with or without failure. 3. Patients with clinical and radio-logical evidence of COPD. 4.Patients with previous history or radio-logical evidence of pulmonary tuberculosis. 5.patients with HIV associated pneumonia. 6.patient not willing to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done, and better outcome of the patient is seen, and as compared to other biomarkers serum BNP is cheaper and more accurate which will help in the diagnosis of community acquired pneumoniaTimepoint: The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done,and the outcome will be assessed at the baseline of admission | — |
Secondary
| Measure | Time frame |
|---|---|
| The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done, and better outcome of the patient is seen, and as compared to other biomarkers serum BNP is cheaper and more accurate which will help in the diagnosis of community acquired pneumoniaTimepoint: The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done, and better outcome of the patient is seen, and as compared to other biomarkers serum BNP is cheaper and more accurate which will help in the diagnosis of community acquired pneumonia | — |
Countries
India
Contacts
S.NIJALINGAPPA MEDICAL COLLEGE AND HANAGA SHRI KUMARESHWARA HOSPITAL